Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Rhizen Pharmaceuticals AG logo — Developing The Next Generation Medicines That Will Lead The...

Rhizen Pharmaceuticals AG

Developing The Next Generation Medicines That Will Lead The Fight Against Cancer

Founded 2012 Switzerland Basel, Switzerland 5 employees Biotechnology, Pharmaceutical

General Information

Company Name Rhizen Pharmaceuticals AG
Founded Year 2012
Location Switzerland Basel, Switzerland +1
Employees 5
Industries Biotechnology, Pharmaceutical
Social

Get notified when Rhizen Pharmaceuticals AG moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Rhizen Pharmaceuticals AG

Rhizen Pharmaceuticals AG is a Swiss HQ biotech company that is dedicated to developing innovative, small molecule drugs for the treatment of cancer & inflammatory diseases. Its slogan, "Developing The Next Generation Medicines That Will Lead The Fight Against Cancer," reflects its commitment to creating impactful solutions. Rhizen has established itself as a leader in the PI3K space with the discovery of Umbralisib & Tenalisib - class leading PI3K isoform-specific inhibitors aimed at transforming the NHL & CLL space. Since its foundation in 2012, the company has built a deep pipeline of novel differentiated assets across various stages of development. As a player in the Biotechnology and Pharmaceutical industries, Rhizen Pharmaceuticals AG is poised for significant growth and impact in the fight against cancer and inflammatory diseases.

Taxonomy: biotech, drug discovery, small molecule drugs, cancer treatment, inflammatory diseases, PI3K inhibitors, clinical-stage biopharmaceutical, signal transduction networks, ion channels, autoimmune diseases, metabolic disorders, virtual company, out sourcing, pre-clinical development, clinical development

No funding data available for Rhizen Pharmaceuticals AG yet.

Get notified when Rhizen Pharmaceuticals AG raises funding

Rhizen Pharmaceuticals AG Alternatives & Competitors

Rhizen Pharmaceuticals AG vs
PRAEVENTIX LLC
PRAEVENTIX LLC

Pioneering the future of healthcare by developing innovative therapies for bowel, dermatologic, auto...

Series Unknown
1 employees
Biotechnology, Health Care
Rhizen Pharmaceuticals AG vs
Semafore Pharmaceuticals
Semafore Pharmaceuticals

Pioneering the future of cancer treatment with innovative PI3K inhibitors.

Series B
Biotechnology, Health Care
Rhizen Pharmaceuticals AG vs
TenNor Therapeutics
TenNor Therapeutics China

Clinical-stage biotechnology company dedicated to discovery and development of therapeutics in infec...

Series D
5 employees
Biotechnology, Health and Wellness

FAQ About Rhizen Pharmaceuticals AG

Developing The Next Generation Medicines That Will Lead The Fight Against Cancer
Rhizen Pharmaceuticals AG was founded in 2012.
Rhizen Pharmaceuticals AG is headquartered in Basel, Switzerland.
Rhizen Pharmaceuticals AG operates in the following industries: Biotechnology, Pharmaceutical.
Rhizen Pharmaceuticals AG has approximately 5 employees.
Top alternatives and competitors to Rhizen Pharmaceuticals AG include PRAEVENTIX LLC, Semafore Pharmaceuticals, TenNor Therapeutics, Flame Biosciences, Athersys. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rhizen Pharmaceuticals AG and PRAEVENTIX LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Rhizen Pharmaceuticals AG and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy